There is a large group of patients with atopic dermatitis who do not receive satisfactory relief from their treatment, yet do not qualify for biologic drugs. We want to study this group, and if our clinical observations are correct, they could benefit greatly from INMEST.

If you are interested in contributing to the study, please contact the foundation, and we will get back to you shortly to discuss the way forward. We are also happy to answer any questions you may have.